+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vivo CRO Market by Type (Non-Rodent, Rodent), Service Type (Clinical Services, Consulting & Strategy, Laboratory Services), Modality, Indication, End User - Global Forecast 2025-2030- Product Image
In Vivo CRO Market by Type (Non-Rodent, Rodent), Service Type (Clinical Services, Consulting & Strategy, Laboratory Services), Modality, Indication, End User - Global Forecast 2025-2030- Product Image
Sale

In Vivo CRO Market by Type (Non-Rodent, Rodent), Service Type (Clinical Services, Consulting & Strategy, Laboratory Services), Modality, Indication, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666068
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In vivo contract research organizations (CROs) play a critical role in bridging innovative research and clinical application, offering specialized expertise that supports drug discovery and preclinical development. This report provides a clear, actionable analysis tailored for senior leaders evaluating opportunities and challenges within the evolving global in vivo CRO market.

Market Snapshot: In Vivo CRO Market Overview

The In Vivo CRO Market grew from USD 6.01 billion in 2024 to USD 6.58 billion in 2025. With a projected CAGR of 9.75%, it is anticipated to reach USD 10.50 billion by 2030. This robust momentum is being driven by rising demands for preclinical research, increasing investment in biologics, and a regulatory climate that emphasizes study rigor and data transparency. Senior stakeholders should note the market’s acceleration amid ongoing scientific and regulatory advancements.

Scope & Segmentation of the In Vivo CRO Market

  • Type: Rodent, Non-Rodent
  • Service Type: Clinical Services, Consulting & Strategy, Laboratory Services, Preclinical Services, Regulatory Services, Toxicological & Safety Assessment
  • Modality: Large Molecules, Small Molecules
  • Indication: Cardiovascular Diseases (Coronary Artery Disease, Heart Failure), Infectious Diseases (Bacterial Infections, Viral Infections), Neurological Disorders (Neurodegenerative Disorders, Psychiatric Disorders), Oncology (Hematological Malignancies, Solid Tumors), Respiratory Disorders (Asthma, Chronic Obstructive Pulmonary Disease)
  • End User: Academic & Research Institutions, Government & Regulatory Organizations, Medical Device Companies, Pharmaceuticals & Biotechnology Companies
  • Regional Coverage: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Coverage: Altogen Labs, Biocytogen Boston Corp., Cellvax SAS, Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific SE, Evotec SE, Explicyte by Immusmol SAS Company, GEMPHARMATECH LLC, ICON Plc, Imavita SAS, IQVIA Holdings Inc., IVRS AB, JSR Corporation, Labcorp Drug Development PRIVATE LIMITED, Medpace Inc., Melior Discovery Inc., Noble Life Sciences Inc., Parexel International Corporation, Pharmacology Discovery Services Ltd., Pharmaron Beijing Co. Ltd., Pharmatest Services Ltd., PPD Inc. by Thermo Fisher Scientific Inc., PSI CRO AG, Syneos Health Inc., Syngene International Limited, Taconic Biosciences Inc., WuXi AppTec Inc., Yecuris Corporation

Key Takeaways for In Vivo CRO Market Leaders

  • Strategic alliances and partnerships are shaping how CROs deliver integrated, end-to-end preclinical solutions across diverse therapeutic modalities.
  • Adoption of advanced imaging and data analytics enhances study efficiency by enabling real-time insights and improving reproducibility in preclinical workflows.
  • Regional regulatory variations drive digital innovation in compliance management and necessitate adaptive operating models, particularly in EMEA and Asia-Pacific markets.
  • Demand for high-quality, standardized data is accelerating CRO investment in robust quality management systems and digital documentation tools aligned with evolving regulatory requirements.
  • Segmented approaches based on species, modality, and indication ensure CROs can tailor service delivery, supporting translational relevance and de-risking preclinical assets for clients.
  • Operational agility, including diversification of suppliers and internalization of key reagent production, is now pivotal for sustaining competitive advantage amid external shocks.

Tariff Impact: Implications of United States Tariffs Enacted in 2025

  • Recent tariffs have elevated import costs for reagents, animal models, and laboratory consumables, prompting a shift toward domestic sourcing and supplier diversification.
  • Many CROs now negotiate volume-based rebates and explore in-house reagent production to preserve budgets and maintain project timelines.
  • Procurement and operational agility continue to differentiate CROs as they mitigate tariff-related vulnerabilities.

Methodology & Data Sources

This analysis draws on in-depth primary interviews with industry leaders and regulatory specialists, as well as a systematic review of peer-reviewed publications, regulatory documents, and corporate disclosures. Data triangulation and validation workshops with independent domain experts ensure accuracy and actionable relevance.

Why This Report Matters to Senior Decision-Makers

  • Equips leaders with granular segmentation insights and operational benchmarks for more informed CRO selection and partnership strategies.
  • Identifies region-specific technical and regulatory dynamics, supporting risk management and tailored business development.
  • Provides clarity on recent market shifts, enabling proactive responses to technology advances and supply chain disruptions.

Conclusion

The in vivo CRO market is rapidly evolving, with digital transformation, regulatory harmonization, and operational innovation standing out as leading strategic themes. Organizations poised to leverage these dynamics will be best positioned for sustained growth and differentiation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for GLP-compliant gene therapy animal models in preclinical pipelines
5.2. Integration of AI-driven image analysis and digital biomarkers in in vivo studies
5.3. Expansion of immuno-oncology animal models to improve translational validity in vivo research
5.4. Adoption of 3D tissue engineering and organoid-based assays to reduce animal testing in drug discovery
5.5. Implementation of wireless telemetry and remote monitoring platforms for real-time animal physiology data
5.6. Focus on personalized humanized mouse models to enhance precision medicine research outcomes
5.7. Increasing collaboration between in vivo CROs and academic institutions for translational oncology studies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. In Vivo CRO Market, by Type
8.1. Introduction
8.2. Non-Rodent
8.3. Rodent
9. In Vivo CRO Market, by Service Type
9.1. Introduction
9.2. Clinical Services
9.3. Consulting & Strategy
9.4. Laboratory Services
9.5. Preclinical Services
9.6. Regulatory Services
9.7. Toxicological & Safety Assessment
10. In Vivo CRO Market, by Modality
10.1. Introduction
10.2. Large Molecules
10.3. Small Molecules
11. In Vivo CRO Market, by Indication
11.1. Introduction
11.2. Cardiovascular Diseases
11.2.1. Coronary Artery Disease
11.2.2. Heart Failure
11.3. Infectious Diseases
11.3.1. Bacterial Infections
11.3.2. Viral Infections
11.4. Neurological Disorders
11.4.1. Neurodegenerative Disorders
11.4.2. Psychiatric Disorders
11.5. Oncology
11.5.1. Hematological Malignancies
11.5.2. Solid Tumors
11.6. Respiratory Disorders
11.6.1. Asthma
11.6.2. Chronic Obstructive Pulmonary Disease
12. In Vivo CRO Market, by End User
12.1. Introduction
12.2. Academic & Research Institutions
12.3. Government & Regulatory Organizations
12.4. Medical Device Companies
12.5. Pharmaceuticals & Biotechnology Companies
13. Americas In Vivo CRO Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa In Vivo CRO Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific In Vivo CRO Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Altogen Labs
16.3.2. Biocytogen Boston Corp.
16.3.3. Cellvax, SAS
16.3.4. Charles River Laboratories International, Inc.
16.3.5. Crown Bioscience, Inc.
16.3.6. Eurofins Scientific SE
16.3.7. Evotec SE
16.3.8. Explicyte by Immusmol SAS Company
16.3.9. GEMPHARMATECH LLC
16.3.10. ICON Plc
16.3.11. Imavita S.A.S.
16.3.12. IQVIA Holdings Inc.
16.3.13. IVRS AB
16.3.14. JSR Corporation
16.3.15. Labcorp Drug Development PRIVATE LIMITED
16.3.16. Medpace, Inc.
16.3.17. Melior Discovery Inc.
16.3.18. Noble Life Sciences Inc.
16.3.19. Parexel International Corporation
16.3.20. Pharmacology Discovery Services Ltd.
16.3.21. Pharmaron Beijing Co., Ltd.
16.3.22. Pharmatest Services Ltd.
16.3.23. PPD Inc. by Thermo Fisher Scientific, Inc.
16.3.24. PSI CRO AG
16.3.25. Syneos Health Inc.
16.3.26. Syngene International Limited
16.3.27. Taconic Biosciences, Inc.
16.3.28. WuXi AppTec, Inc.
16.3.29. Yecuris Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. IN VIVO CRO MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IN VIVO CRO MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IN VIVO CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN VIVO CRO MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IN VIVO CRO MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IN VIVO CRO MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IN VIVO CRO MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. IN VIVO CRO MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. IN VIVO CRO MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. IN VIVO CRO MARKET: RESEARCHAI
FIGURE 26. IN VIVO CRO MARKET: RESEARCHSTATISTICS
FIGURE 27. IN VIVO CRO MARKET: RESEARCHCONTACTS
FIGURE 28. IN VIVO CRO MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IN VIVO CRO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IN VIVO CRO MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IN VIVO CRO MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IN VIVO CRO MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IN VIVO CRO MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IN VIVO CRO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IN VIVO CRO MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IN VIVO CRO MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IN VIVO CRO MARKET SIZE, BY CONSULTING & STRATEGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IN VIVO CRO MARKET SIZE, BY CONSULTING & STRATEGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IN VIVO CRO MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IN VIVO CRO MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IN VIVO CRO MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IN VIVO CRO MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IN VIVO CRO MARKET SIZE, BY REGULATORY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IN VIVO CRO MARKET SIZE, BY REGULATORY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IN VIVO CRO MARKET SIZE, BY TOXICOLOGICAL & SAFETY ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IN VIVO CRO MARKET SIZE, BY TOXICOLOGICAL & SAFETY ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IN VIVO CRO MARKET SIZE, BY LARGE MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IN VIVO CRO MARKET SIZE, BY LARGE MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IN VIVO CRO MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IN VIVO CRO MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IN VIVO CRO MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IN VIVO CRO MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IN VIVO CRO MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IN VIVO CRO MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IN VIVO CRO MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IN VIVO CRO MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IN VIVO CRO MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IN VIVO CRO MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IN VIVO CRO MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IN VIVO CRO MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IN VIVO CRO MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IN VIVO CRO MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IN VIVO CRO MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IN VIVO CRO MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IN VIVO CRO MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IN VIVO CRO MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IN VIVO CRO MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IN VIVO CRO MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IN VIVO CRO MARKET SIZE, BY GOVERNMENT & REGULATORY ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IN VIVO CRO MARKET SIZE, BY GOVERNMENT & REGULATORY ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IN VIVO CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IN VIVO CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IN VIVO CRO MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IN VIVO CRO MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 136. CANADA IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 137. CANADA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 140. CANADA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 141. CANADA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 142. CANADA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 143. CANADA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 144. CANADA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 145. CANADA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 146. CANADA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 147. CANADA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 148. CANADA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 149. CANADA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. CANADA IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 160. MEXICO IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 161. MEXICO IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 162. MEXICO IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 163. MEXICO IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. GERMANY IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 256. GERMANY IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 257. GERMANY IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 258. GERMANY IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 259. GERMANY IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. GERMANY IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. GERMANY IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 262. GERMANY IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 263. GERMANY IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 264. GERMANY IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 265. GERMANY IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 269. GERMANY IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. GERMANY IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. FRANCE IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 274. FRANCE IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 275. FRANCE IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 278. FRANCE IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 279. FRANCE IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. FRANCE IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. FRANCE IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 282. FRANCE IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 283. FRANCE IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 284. FRANCE IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 285. FRANCE IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 288. FRANCE IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 289. FRANCE IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 290. FRANCE IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 291. FRANCE IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. FRANCE IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. ITALY IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 314. ITALY IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 315. ITALY IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 316. ITALY IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 317. ITALY IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 318. ITALY IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 319. ITALY IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 320. ITALY IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 321. ITALY IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 322. ITALY IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 323. ITALY IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 324. ITALY IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 325. ITALY IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 326. ITALY IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 327. ITALY IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 328. ITALY IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 329. ITALY IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 330. ITALY IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 331. ITALY IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. ITALY IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. SPAIN IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 334. SPAIN IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 335. SPAIN IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 336. SPAIN IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 337. SPAIN IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 338. SPAIN IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 339. SPAIN IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 340. SPAIN IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 341. SPAIN IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 342. SPAIN IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 343. SPAIN IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 344. SPAIN IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 345. SPAIN IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 346. SPAIN IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 347. SPAIN IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 348. SPAIN IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 349. SPAIN IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 350. SPAIN IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 351. SPAIN IN VIVO CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. SPAIN IN VIVO CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this In Vivo CRO market report include:
  • Altogen Labs
  • Biocytogen Boston Corp.
  • Cellvax, SAS
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • Explicyte by Immusmol SAS Company
  • GEMPHARMATECH LLC
  • ICON Plc
  • Imavita S.A.S.
  • IQVIA Holdings Inc.
  • IVRS AB
  • JSR Corporation
  • Labcorp Drug Development PRIVATE LIMITED
  • Medpace, Inc.
  • Melior Discovery Inc.
  • Noble Life Sciences Inc.
  • Parexel International Corporation
  • Pharmacology Discovery Services Ltd.
  • Pharmaron Beijing Co., Ltd.
  • Pharmatest Services Ltd.
  • PPD Inc. by Thermo Fisher Scientific, Inc.
  • PSI CRO AG
  • Syneos Health Inc.
  • Syngene International Limited
  • Taconic Biosciences, Inc.
  • WuXi AppTec, Inc.
  • Yecuris Corporation

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.5 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type, By Modality, By Indication, By GLP Type, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type, By Modality, By Indication, By GLP Type, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Oncology Based In-Vivo CRO Market by Animal Model (Murine, Non Murine), Route Of Administration (Intravenous, Oral, Subcutaneous), Therapeutic Modality, End User - Global Forecast 2025-2030 - Product Image

Oncology Based In-Vivo CRO Market by Animal Model (Murine, Non Murine), Route Of Administration (Intravenous, Oral, Subcutaneous), Therapeutic Modality, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
In-vivo CRO Market Report by Type, GLP Type, Indication, and Region 2025-2033 - Product Image

In-vivo CRO Market Report by Type, GLP Type, Indication, and Region 2025-2033

  • Report
  • 146 Pages
  • Global
From
In Vivo Contract Research Organization (CRO) - Global Strategic Business Report - Product Image

In Vivo Contract Research Organization (CRO) - Global Strategic Business Report

  • Report
  • 220 Pages
  • Global
From
In-Vivo CRO - Global Strategic Business Report - Product Image

In-Vivo CRO - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From

About the In Vivo CRO Market

The In Vivo CRO market is a subset of the biotechnology industry that focuses on providing contract research services to pharmaceutical and biotechnology companies. These services include preclinical and clinical trials, drug development, and regulatory affairs. In Vivo CRO companies provide expertise in areas such as pharmacology, toxicology, and clinical research. They also provide services such as data management, biostatistics, and medical writing. In Vivo CRO companies are typically small to medium-sized businesses that specialize in a particular area of research. They are often located in countries with a strong biotechnology industry, such as the United States, Canada, and Europe. Some companies in the In Vivo CRO market include Charles River Laboratories, Covance, Parexel, and Quintiles. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.